Two Sigma Securities’s GSK GSK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-7,353
| Closed | -$285K | – | 1735 |
|
|
2025
Q1 | $285K | Buy |
+7,353
| New | +$269K | 0.04% | 621 |
|
|
2024
Q1 | – | Sell |
-18,387
| Closed | -$758K | – | 3209 |
|
|
2023
Q4 | $681K | Sell |
18,387
-15,277
| -45% | -$548K | 0.01% | 1315 |
|
|
2023
Q3 | $1.22M | Sell |
33,664
-18,206
| -35% | -$646K | 0.01% | 913 |
|
|
2023
Q2 | $1.85M | Buy |
51,870
+6,173
| +14% | +$221K | 0.03% | 648 |
|
|
2023
Q1 | $1.63M | Buy |
+45,697
| New | +$1.6M | 0.03% | 607 |
|
|
2022
Q3 | – | Sell |
-7,487
| Closed | -$407K | – | 2788 |
|
|
2022
Q2 | $407K | Buy |
+7,487
| New | +$413K | 0.01% | 1059 |
|
|
2021
Q4 | – | Sell |
-16,574
| Closed | -$792K | – | 1742 |
|
|
2021
Q3 | $792K | Buy |
16,574
+11,213
| +209% | +$563K | 0.02% | 598 |
|
|
2021
Q2 | $267K | Sell |
5,361
-794
| -13% | -$38.2K | 0.01% | 1072 |
|
|
2021
Q1 | $275K | Buy |
+6,155
| New | +$279K | 0.02% | 470 |
|
|
2020
Q1 | – | Sell |
-3,819
| Closed | -$224K | – | 1721 |
|
|
2019
Q4 | $224K | Sell |
3,819
-2,559
| -40% | -$142K | ﹤0.01% | 2006 |
|
|
2019
Q3 | $340K | Buy |
+6,378
| New | +$328K | ﹤0.01% | 1452 |
|
|
2019
Q1 | – | Sell |
-28,721
| Closed | -$1.44M | – | 2058 |
|
|
2018
Q4 | $1.37M | Buy |
+28,721
| New | +$1.41M | 0.02% | 506 |
|
|
2018
Q3 | – | Sell |
-8,915
| Closed | -$453K | – | 2736 |
|
|
2018
Q2 | $449K | Sell |
8,915
-1,922
| -18% | -$96.8K | ﹤0.01% | 1811 |
|
|
2018
Q1 | $529K | Buy |
10,837
+2,271
| +27% | +$106K | ﹤0.01% | 1624 |
|
|
2017
Q4 | $380K | Buy |
+8,566
| New | +$396K | 0.01% | 854 |
|
|
2017
Q3 | – | Sell |
-4,440
| Closed | -$239K | – | 1034 |
|
|
2017
Q2 | $239K | Buy |
+4,440
| New | +$237K | 0.05% | 456 |
|
|
2017
Q1 | – | Sell |
-10,624
| Closed | -$511K | – | 981 |
|
|
2016
Q4 | $511K | Buy |
+10,624
| New | +$525K | 0.17% | 143 |
|
|
2016
Q3 | – | Sell |
-5,039
| Closed | -$273K | – | 711 |
|
|
2016
Q2 | $273K | Buy |
+5,039
| New | +$265K | 0.15% | 188 |
|
|
2015
Q4 | – | Sell |
-4,164
| Closed | -$200K | – | 316 |
|
|
2015
Q3 | $200K | Sell |
4,164
-19,892
| -83% | -$1.04M | 0.31% | 131 |
|
|
2015
Q2 | $1.25M | Buy |
+24,056
| New | +$1.35M | 2.09% | 8 |
|
Other funds holding GSK
JEST
Two Sigma Securities's GSK Position: Q2 2025 in Review
Two Sigma Securities sold out of GSK (GSK) in Q2 2025, closing a stake of 7,353 shares — an estimated $285K sold.
Two Sigma Securities first reported a position in GSK in Q2 2015 and held it in 20 quarters. The position peaked at $1.85M in Q2 2023. 891 funds tracked by Wall St. Rank hold GSK as of Q2 2025.
- Two Sigma Securities reported no remaining GSK position as of Q2 2025 after selling out during the quarter.
- Two Sigma Securities sold 7,353 GSK shares in Q2 2025, an estimated $285K.
- Two Sigma Securities first reported a position in GSK in Q2 2015 and held it in 20 quarters.
- Two Sigma Securities's GSK position peaked at $1.85M in Q2 2023.
- 891 funds tracked by Wall St. Rank held GSK as of Q2 2025.
Based on Two Sigma Securities's 13F filing for Q2 2025, filed 14 Aug 2025.